Leica Biosystems launches The ExperienceLAB tour providing laboratories with the ability to “Take a look inside tomorrow's lab.”
FOR IMMEDIATE RELEASE
Media Contact(s): Tim Lyons, Director, Global Marketing Communications, Tim.Lyons@LeicaBiosystems.com, 847-405-5455
LEICA BIOSYSTEMS LAUNCHES THE EXPERIENCELAB TOUR PROVIDING LABORATORIES WITH THE ABILITY TO “TAKE A LOOK INSIDE TOMORROW’S LAB.”
Buffalo Grove, IL, USA, - Leica Biosystems announced the launch of the EXPERIENCELAB tour, a mobile demonstration lab that showcases Leica’s full line of anatomical pathology solutions. Customers will be able to visit the EXPERIENCELAB as it moves across North America. This will be an opportunity to receive continuing education (CE) credits, listen to guest speakers, and interact with Leica’s team to understand innovative solutions developed to meet their pathology needs.
“Leica Biosystems is pleased to be able to bring its comprehensive portfolio of product solutions right to your laboratory. With an innovative mobile pathology laboratory, our customers will be able to see what tomorrow’s lab will look like today.” said Chip Clark, Leica Biosystems, Vice President North America Marketing.
Leica Biosystems provides a comprehensive product solution for each step in the pathology process. Its history of market firsts, industry collaboration and cutting edge research and development gives the laboratory the ability to deliver increased diagnostic confidence for the benefit of patients.
“Leica Biosystems is committed to the healthcare industry. Through this unique EXPERIENCELAB , Leica customers can experience the benefits of Leica’s solutions delivering improved workflow and reduced turnaround time.” commented Michael Cusack, Senior Vice President, Leica Biosystems, North America.
Leica Biosystems invites its customers to share in the vision of Tomorrow’s Lab. The Leica Biosystems EXPERIENCELAB tour will be touring North America from April 16, 2013.
About Leica Biosystems
Leica Biosystems is a global leader in workflow solutions and automation, striving to advance cancer diagnostics to improve patients’ lives. Leica Biosystems provides anatomical pathology laboratories and researchers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. Leica’s easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 6 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Further information can be found at www.LeicaBiosystems.com